Intervention Toward Truth-Telling and Advanced Directives in the Patient With Advanced or Metastatic Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by National Taiwan University Hospital.
Recruitment status was  Recruiting
National Science Council, Taiwan
Information provided by:
National Taiwan University Hospital Identifier:
First received: November 16, 2008
Last updated: November 17, 2008
Last verified: May 2008
Family usually had a lot of burden to tell the truth to patients. The purpose of this study is to assess the effect of education materials and family conference for advanced cancer patients and family.

Condition Intervention
Advanced Cancer
Metastatic Cancer
Behavioral: family conference

Study Type: Interventional
Study Design: Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: A Longitudinal Study That Assessed the Effectiveness of Intervention Toward

Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:
  • Questionnaires [ Time Frame: before and 1 week after the intervention ] [ Designated as safety issue: No ]

Estimated Enrollment: 150
Study Start Date: May 2008
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Family conference + education materials
Behavioral: family conference
family conference
No Intervention: 2
education materials


Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • advanced or metastatic cancer patients
  • more than 20 years old
  • clear consciousness and be able to communicate

Exclusion Criteria:

  • refuse to know the statement of himself/herself disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00792896

Contact: We-Yu Hu, Ph.D 23123456 ext 88428

National Taiwan University Hospital Recruiting
Taipei, Taiwan, 100
Contact: We-Yu Hu, Ph.D    23123456 ext 88428   
Principal Investigator: We-Yu Hu, Ph.D         
Sponsors and Collaborators
National Taiwan University Hospital
National Science Council, Taiwan
  More Information

Responsible Party: 1, Jen-Ai Road Section 1, Taipei, Taiwan, Department of Nursing Identifier: NCT00792896     History of Changes
Other Study ID Numbers: 200803051R 
Study First Received: November 16, 2008
Last Updated: November 17, 2008
Health Authority: Taiwan: Department of Health

Additional relevant MeSH terms:
Neoplasm Metastasis
Neoplastic Processes
Pathologic Processes processed this record on May 26, 2016